Pastāsti draugiem par šo preci:
Resistance to Targeted Therapies in Breast Cancer 1st ed. 2017 edition
Resistance to Targeted Therapies in Breast Cancer
We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).
184 pages, 12 Illustrations, black and white; XV, 184 p. 12 illus.
| Mediji | Grāmatas Book |
| Izlaists | 2017. gada 13. decembris |
| ISBN13 | 9783319701417 |
| Izdevēji | Springer International Publishing AG |
| Lapas | 184 |
| Izmēri | 150 × 220 × 20 mm · 471 g |
| Valoda | Vācu |
| Redaktors | Prosperi, Jenifer R. |